Balverde, Judy Ann D.

HRN: 14-39-40  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2025
AMPICILLIN 1GM (VIAL)
12/20/2025
12/21/2025
IV
2gms
Q6hrs Until Delivery
PROM X 6 Hrs
Checking Initial Appropriateness 
12/21/2025
CO-AMOXICLAV 625MG (TAB)
12/21/2025
12/28/2025
ORAL
500mg
BID
S/P NSD With Repair; PROM
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: